Results 1 to 10 of about 9,775 (218)

Spectrophotometric Determination of Methimazole by Silicomolybdenum Blue

open access: yesE3S Web of Conferences, 2018
Under optimum reaction conditions, Ammonium silicomolybdate could be quantitatively reduced to silicomolybdenum blue by hydrosulfuryl(-SH) in methimazole molecule, and the content of methimazole was determinated indirectly through determinating the ...
Wen Xinrong, Tu Changqing
doaj   +2 more sources

From antithyroid therapy to oral necrosis: oral manifestations of methimazole-induced agranulocytosis: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Methimazole is a widely used antithyroid medication with a well-documented risk of hematological adverse effects, particularly agranulocytosis.
Haitham Medhioub   +5 more
doaj   +2 more sources

Methimazole-Induced Pleural Effusion in the Setting of Graves’ Disease

open access: yesCase Reports in Endocrinology, 2019
Methimazole is a thionamide drug that inhibits the synthesis of thyroid hormones by blocking the oxidation of iodine in the thyroid gland. We report a case of methimazole-induced recurrent pleural effusion.
Le Yu Khine   +5 more
doaj   +2 more sources

The Role of Endoplasmic Reticulum Stress in Cell Injury Induced by Methimazole on Pancreatic Cells [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2023
Purpose: Methimazole is an anti-thyroid agent, especially as main therapy option for Graves’ disease in children and adults. Drug induced pancreatitis is one of the known adverse effect of methimazole mentioned in case reports.
Özge Yazıcı   +3 more
doaj   +2 more sources

Effects of methimazole on the elimination of irinotecan [PDF]

open access: yesCancer Chemotherapy and Pharmacology, 2010
To study the possible pharmacokinetic and pharmacodynamic interactions between irinotecan and methimazole.A patient treated for colorectal cancer with single agent irinotecan received methimazole co-medication for Graves' disease. Irinotecan pharmacokinetics and side effects were followed during a total of four courses (two courses with and two courses
van der Bol, J.M.   +9 more
core   +7 more sources

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use

open access: yesCase Reports in Endocrinology, 2015
ANCA-associated vasculitis (AAV) is a rare and potentially life threatening complication associated with antithyroid drug use. It is more commonly reported with propylthiouracil, with fewer cases reported with methimazole use. We present the case of a 55-
Deep Shikha   +3 more
doaj   +2 more sources

Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism [PDF]

open access: yesCase Reports in Endocrinology, 2015
Maternal Graves’ disease is relatively uncommon with an estimated incidence of 0.4%–1% of all pregnancies, but only 1–5% of newborns delivered to mothers with Graves’ disease develop overt clinical signs and symptoms of hyperthyroidism. Here, we describe
Dimitrios Angelis   +2 more
doaj   +2 more sources

Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
Drug-induced pancreatitis represents 1.1% of acute pancreatitis cases. To date, eight cases of antithyroid drug (ATD)-induced pancreatitis have been reported, including seven associated with methimazole (MMI) and one with carbimazole; however, no cases ...
Yuriko Yamazaki   +8 more
doaj   +2 more sources

A case of severe erythema nodosum induced by methimazole

open access: yesSaudi Pharmaceutical Journal, 2017
Erythema nodosum (EN), is the most common variant of septal panniculitis and is possibly a delayed hypersensitivity reaction triggered by a wide range of antigenic stimuli.
Selma Emre   +4 more
doaj   +2 more sources

Methimazole

open access: yes, 2006
James L. Schardein, Orest T. Macina
europepmc   +4 more sources

Home - About - Disclaimer - Privacy